BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26604062)

  • 1. Transfemoral Implantation of a Fully Repositionable and Retrievable Transcatheter Valve for Noncalcified Pure Aortic Regurgitation.
    Schofer J; Nietlispach F; Bijuklic K; Colombo A; Gatto F; De Marco F; Mangieri A; Hansen L; Bruschi G; Ruparelia N; Rieß FC; Maisano F; Latib A
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1842-9. PubMed ID: 26604062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
    Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation.
    Yoon SH; Schmidt T; Bleiziffer S; Schofer N; Fiorina C; Munoz-Garcia AJ; Yzeiraj E; Amat-Santos IJ; Tchetche D; Jung C; Fujita B; Mangieri A; Deutsch MA; Ubben T; Deuschl F; Kuwata S; De Biase C; Williams T; Dhoble A; Kim WK; Ferrari E; Barbanti M; Vollema EM; Miceli A; Giannini C; Attizzani GF; Kong WKF; Gutierrez-Ibanes E; Jimenez Diaz VA; Wijeysundera HC; Kaneko H; Chakravarty T; Makar M; Sievert H; Hengstenberg C; Prendergast BD; Vincent F; Abdel-Wahab M; Nombela-Franco L; Silaschi M; Tarantini G; Butter C; Ensminger SM; Hildick-Smith D; Petronio AS; Yin WH; De Marco F; Testa L; Van Mieghem NM; Whisenant BK; Kuck KH; Colombo A; Kar S; Moris C; Delgado V; Maisano F; Nietlispach F; Mack MJ; Schofer J; Schaefer U; Bax JJ; Frerker C; Latib A; Makkar RR
    J Am Coll Cardiol; 2017 Dec; 70(22):2752-2763. PubMed ID: 29191323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Transcatheter Aortic Valve Replacement System for Predominant Aortic Regurgitation Implantation of the J-Valve and Early Outcome.
    Wei L; Liu H; Zhu L; Yang Y; Zheng J; Guo K; Luo H; Zhao W; Yang X; Maimaiti A; Wang C
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1831-41. PubMed ID: 26604056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up.
    Schlingloff F; Schäfer U; Frerker C; Schmoeckel M; Bader R
    Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):388-93. PubMed ID: 24893871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation.
    Seiffert M; Bader R; Kappert U; Rastan A; Krapf S; Bleiziffer S; Hofmann S; Arnold M; Kallenbach K; Conradi L; Schlingloff F; Wilbring M; Schäfer U; Diemert P; Treede H
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1168-74. PubMed ID: 25129672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
    Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort.
    Schulz E; Jabs A; Tamm A; Herz P; Schulz A; Gori T; von Bardeleben S; Kasper-König W; Hink U; Vahl CF; Münzel T
    Int J Cardiol; 2017 Apr; 232():186-191. PubMed ID: 28089455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study.
    Meredith Am IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Allocco DJ; Dawkins KD
    J Am Coll Cardiol; 2014 Sep; 64(13):1339-48. PubMed ID: 25257635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study.
    Sawaya FJ; Deutsch MA; Seiffert M; Yoon SH; Codner P; Wickramarachchi U; Latib A; Petronio AS; Rodés-Cabau J; Taramasso M; Spaziano M; Bosmans J; Biasco L; Mylotte D; Savontaus M; Gheeraert P; Chan J; Jørgensen TH; Sievert H; Mocetti M; Lefèvre T; Maisano F; Mangieri A; Hildick-Smith D; Kornowski R; Makkar R; Bleiziffer S; Søndergaard L; De Backer O
    JACC Cardiovasc Interv; 2017 May; 10(10):1048-1056. PubMed ID: 28521923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfemoral Implantation of the Acurate neo for the Treatment of Aortic Regurgitation.
    Toggweiler S; Cerillo AG; Kim WK; Biaggi P; Lloyd C; Hilker M; Almagor Y; Cuculi F; Brinkert M; Kobza R; Muller O; Rück A; Corti R
    J Invasive Cardiol; 2018 Sep; 30(9):329-333. PubMed ID: 30012890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience.
    Abdel-Wahab M; Comberg T; Büttner HJ; El-Mawardy M; Chatani K; Gick M; Geist V; Richardt G; Neumann FJ;
    JACC Cardiovasc Interv; 2014 Mar; 7(3):284-92. PubMed ID: 24650401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world multicentre experience with the Direct Flow Medical repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis.
    Naber CK; Pyxaras SA; Ince H; Latib A; Frambach P; den Heijer P; Wagner D; Butter C; Colombo A; Kische S
    EuroIntervention; 2016 Feb; 11(11):e1314-20. PubMed ID: 26865450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfemoral Transcatheter Aortic Valve-in-Valve Implantation for Aortic Valve Bioprosthesis Failure With the Fully Repositionable and Retrievable Lotus Valve: A Single-Center Experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    J Invasive Cardiol; 2017 Sep; 29(9):315-319. PubMed ID: 28706126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation.
    Roy DA; Schaefer U; Guetta V; Hildick-Smith D; Möllmann H; Dumonteil N; Modine T; Bosmans J; Petronio AS; Moat N; Linke A; Moris C; Champagnac D; Parma R; Ochala A; Medvedofsky D; Patterson T; Woitek F; Jahangiri M; Laborde JC; Brecker SJ
    J Am Coll Cardiol; 2013 Apr; 61(15):1577-84. PubMed ID: 23433565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
    Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
    Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.